Medicine & Life Sciences
Radiopharmaceuticals
83%
Radiation
59%
Nuclear Medicine
54%
Radiation Protection
42%
Software
39%
Radiometry
33%
Publications
30%
Radioisotopes
29%
Iodides
29%
Interventional Radiology
28%
Fluorodeoxyglucose F18
28%
Thromboplastin
23%
Single Photon Emission Computed Tomography Computed Tomography
22%
Radiation Monitoring
20%
Positron-Emission Tomography
19%
Nuclear Power Plants
19%
Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))
18%
Thyroid Gland
17%
Urinary Bladder
17%
Indium
16%
X-Rays
15%
Ponds
14%
Neoplasms
14%
Computer Security
14%
Multimodal Imaging
13%
Ionizing Radiation
13%
Radiation Dosimeters
12%
Molecular Imaging
12%
Pets
11%
Thyroid Diseases
11%
Fluorides
11%
Prostatic Neoplasms
11%
Gelatin
11%
Feasibility Studies
10%
Calibration
10%
Crystalline Lens
10%
Breast Feeding
10%
Cardiology
10%
Sweden
10%
Tomography
10%
Plastics
10%
Raclopride
9%
Emergencies
9%
Population
9%
Uncertainty
9%
Radiation Exposure
9%
Positron Emission Tomography Computed Tomography
8%
Gamma Cameras
8%
Fetus
8%
Radiation-Induced Neoplasms
8%
Physics & Astronomy
dosage
100%
dosimeters
91%
organs
44%
radiation protection
43%
radiation
39%
computer programs
36%
cancer
36%
radiology
30%
computer aided design
24%
nuclear medicine
21%
radioactive isotopes
19%
contamination
18%
multiple docking adapters
16%
tomography
16%
pregnancy
15%
decommissioning
15%
fetuses
14%
emergencies
13%
nuclear power plants
12%
sediments
12%
estimates
11%
quality control
11%
iodides
9%
life (durability)
8%
coefficients
8%
manufacturing
8%
kidneys
8%
bones
8%
simulation
7%
recommendations
7%
graphical user interface
7%
x rays
6%
optimization
6%
bladder
6%
dredging
6%
physicians
5%
silicon
5%
positrons
5%
filters
5%
liver
5%
fluorides
5%
Social Sciences
radiation protection
40%
cancer
24%
data processing program
22%
environmental pollution
22%
monitoring
16%
simulation
13%
emergency situation
13%
medicine
13%
nuclear power plant
11%
weighting
10%
staff
8%
pregnancy
8%
Contaminated sites
8%
software
7%
Emergency Preparedness
6%
diagnostic
6%
gender
5%